Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Dexamphetamine SR in Cocaine Addiction
NCT02768441Phase 1Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dextroamphetamine in cocaine use disorder (CUD), sponsored by Netherlands Cancer Institute. Primary endpoints: Area under the Curve at 5 days, Maximum plasma concentration at 5 days and 1 more. Started Nov 2016; status: completed.
02
Drugs
dextroamphetamine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT02768441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768441.